Sporotrichosis: Spectrum and Complications

Main Article Content

Ángel Ignacio Garza Zamora
José María Revilla Apodaca
Diego Mendoza Contreras

Abstract

Sporotrichosis, a fungal infection caused by the Sporothrix genus, predominantly presents as cutaneous disease following inoculation through minor skin trauma. Environmental exposure, often linked to soil, plants, or infected animals, is a common source of acquisition. The spectrum of the disease ranges from localized skin lesions to severe disseminated forms, with manifestations including osteoarticular involvement and rare occurrences of meningitis. Prompt diagnosis, typically achieved through culture, is vital for effective management. Treatment, primarily employing antifungal agents like amphotericin B and itraconazole, is essential, as spontaneous resolution is rare. The prognosis varies, with localized infections responding well to treatment, while extracutaneous forms, especially in immunocompromised individuals, may lead to complications and poorer outcomes. Meningitis poses a significant challenge due to limited therapeutic options and diagnostic complexities.

Article Details

How to Cite
Ángel Ignacio Garza Zamora, José María Revilla Apodaca, & Diego Mendoza Contreras. (2023). Sporotrichosis: Spectrum and Complications. International Journal of Medical Science and Clinical Research Studies, 3(12), 3142–3144. https://doi.org/10.47191/ijmscrs/v3-i12-40
Section
Articles

References

I. Rodrigues, A. M., De Hoog, G., Zhang, Y., & De Camargo, Z. P. (2014). Emerging sporotrichosis is driven by clonal and recombinant Sporothrix species. Emerging microbes & infections, 3(1), 1-10.

II. Chakrabarti, A., Bonifaz, A., Gutierrez-Galhardo, M. C., Mochizuki, T., & Li, S. (2014). Global epidemiology of sporotrichosis. Sabouraudia, 53(1), 3-14.

III. Orofino-Costa, R., Macedo, P. M. D., Rodrigues, A. M., & Bernardes-Engemann, A. R. (2017). Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. Anais brasileiros de dermatologia, 92, 606-620.

IV. Rios-Fabra, A., Moreno, A. R., & Isturiz, R. E. (1994). Fungal infection in Latin American countries. Infectious Disease Clinics of North America, 8(1), 129-154.

V. Mahajan, V. K. (2014). Sporotrichosis: an overview and therapeutic options. Dermatology research and practice, 2014.

VI. Zancope-Oliveira, R. M., Almeida-Paes, R., Oliveira, M. M. E., Freitas, D. F. S., & Gutierrez-Galhardo, M. C. (2011). New diagnostic applications in sporotrichosis. Skin biopsy-perspectives. Rijeka: InTech Europe, 53-72.

VII. Kauffman, C. A., Hajjeh, R., Chapman, S. W., & Mycoses Study Group. (2000). Practice guidelines for the management of patients with sporotrichosis. Clinical Infectious Diseases, 30(4), 684-687.

VIII. Saeed, L., Weber, R. J., Puryear, S. B., Bahrani, E., Peluso, M. J., Babik, J. M., ... & Coates, S. J. (2019, October). Disseminated cutaneous and osteoarticular sporotrichosis mimicking pyoderma gangrenosum. In Open Forum Infectious Diseases (Vol. 6, No. 10, p. ofz395). US: Oxford University Press.

IX. Al-Qattan, M. M., & Helmi, A. A. (2014). Chronic hand infections. The Journal of Hand Surgery, 39(8), 1636-1645.

X. Queiroz-Telles, F., Buccheri, R., & Benard, G. (2019). Sporotrichosis in immunocompromised hosts. Journal of Fungi, 5(1), 8.

XI. Kauffman, C. A., & Miceli, M. H. (2023). Sporotrichosis. In Diagnosis and Treatment of Fungal Infections (pp. 329-338). Cham: Springer International Publishing.

XII. Pinto-Almazán, R., Sandoval-Navarro, K. A., Damián-Magaña, E. J., Arenas, R., Fuentes-Venado, C. E., Zárate-Segura, P. B., ... & Rodríguez-Cerdeira, C. (2023). Relationship of Sporotrichosis and Infected Patients with HIV-AIDS: An Actual Systematic Review. Journal of Fungi, 9(4), 396.

XIII. Sharma, B., Sharma, A. K., & Sharma, U. (2022). Sporotrichosis: A comprehensive review on recent drug-based therapeutics and management. Current Dermatology Reports, 11(2), 110-119.

Most read articles by the same author(s)